| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2009;40:e481.)
© 2009 American Heart Association, Inc.
Cochrane Corner |
From the Department of Neurology (H.M.D.H., D.W.J.D.), Erasmus Medical Center, Rotterdam, The Netherlands; the Department of Neurology (H.B.v.d.W.), Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, The Netherlands; and the Department of Business Management (M.-C.T.), National Sun Yat-Sen University, Kaohsiung, Taiwan.
Correspondence to Heleen den Hertog, Department of Neurology, Erasmus MC University Medical Center, Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands. E-mail m.denhertog@erasmusmc.nl
Graeme J. Hankey MD, FRCP Section Editor:
Key Words: stroke body temperature temperature-lowering therapy clinical outcome
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
| Introduction |
|---|
In animal models of focal cerebral ischemia, cooling reduces infarct volume. Hypothermia is successfully used in cardiac surgery and has been associated with a more favorable neurological outcome in patients who were resuscitated after cardiac arrest.
These observations suggest that reduction of body temperature and prevention of fever may improve functional outcome after stroke. However, the potentially beneficial effects of temperature-lowering therapy might be offset by side effects such as infections, cardiac arrhythmias, hemorrhagic transformation of infarcts, and deep venous thrombosis.
| Objectives |
|---|
| Search Strategy |
|---|
| Selection Criteria |
|---|
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |